Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ivanoiu

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Neuroimage|February 7, 1998
Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patientsJ Blin, A Ivanoiu, A Coppens, et al.
IEEE Transactions on Medical Imaging|July 23, 1999
A standardized blood sampling scheme in quantitative FDG-PET studiesM Bentourkia, A Bol, A Ivanoiu, et al.
Acta Neurologica Belgica|February 28, 2007
Clinical, electrophysiological and brain imaging features during recurrent ictal cortical blindness associated with chronic liver failureV van Pesch, D Hernalsteen, K van Rijckevorsel, et al.
Psychopharmacology|May 5, 1998
Physostigmine results in an increased decrement in brain glucose consumption in Alzheimer's diseaseJ Blin, A Ivanoiu, A De Volder, et al.
Journal of the Neurological Sciences|December 2, 2000
Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of agingM Bentourkia, A Bol, A Ivanoiu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography studyE L Constant, A G de Volder, A Ivanoiu, et al.
Neurology|May 20, 1999
Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSFF Hulstaert, K Blennow, A Ivanoiu, et al.
Molecular Psychiatry|October 21, 2015
The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoterI Gijselinck, S Van Mossevelde, J van der Zee, et al.
The Journal of Prevention of Alzheimer'S Disease|October 1, 2024
Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) InvestigatorsF Jessen, M G Kramberger, D Angioni, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Neuroimage|February 7, 1998
Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patientsJ Blin, A Ivanoiu, A Coppens, et al.
IEEE Transactions on Medical Imaging|July 23, 1999
A standardized blood sampling scheme in quantitative FDG-PET studiesM Bentourkia, A Bol, A Ivanoiu, et al.
Acta Neurologica Belgica|February 28, 2007
Clinical, electrophysiological and brain imaging features during recurrent ictal cortical blindness associated with chronic liver failureV van Pesch, D Hernalsteen, K van Rijckevorsel, et al.
Psychopharmacology|May 5, 1998
Physostigmine results in an increased decrement in brain glucose consumption in Alzheimer's diseaseJ Blin, A Ivanoiu, A De Volder, et al.
Journal of the Neurological Sciences|December 2, 2000
Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of agingM Bentourkia, A Bol, A Ivanoiu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography studyE L Constant, A G de Volder, A Ivanoiu, et al.
Neurology|May 20, 1999
Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSFF Hulstaert, K Blennow, A Ivanoiu, et al.
Molecular Psychiatry|October 21, 2015
The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoterI Gijselinck, S Van Mossevelde, J van der Zee, et al.
The Journal of Prevention of Alzheimer'S Disease|October 1, 2024
Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) InvestigatorsF Jessen, M G Kramberger, D Angioni, et al.
Pageof 2